Jump to content
Health NZ Taranaki Lab Manual

Tests:Cholesterol-HDL Ratio, Plasma: Difference between revisions

Department
Biochemistry
Tests:Cholesterol-HDL Ratio, Plasma
No edit summary
No edit summary
Line 25: Line 25:
|-
|-
|Specimen Type
|Specimen Type
|6 mL <span style="background:#e30022"> red top</span>, or 4 mL Li-Hep </span> or  Li-Hep <span style="background:#3cb371"> green-top </span>  
|Plasma
|-
Serum
|Specimen Transportation
|
|-
|-
|Preferred
|Preferred
|
|6 mL <span style="background:#e30022"> Red-Top</span>
|-
|-
|Acceptable
|Acceptable
|4 mL  Li-Hep <span style="background:#3cb371"> Green-Top </span>  
|-
|Specimen Transportation
|
|
|-
|-
|Pediatric Requirements
|Pediatric Requirements
|Heparin microtainer tube 600 µL 
|600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span> Paediatric tube
|-
|-
! colspan="2" |
! colspan="2" |
Line 48: Line 49:
|
|
|-
|-
|Aliquot Transportation
| Aliquot Transportation
|
|
|-
|-
Line 57: Line 58:
|
|
|-
|-
|Test Method
|Test Method  
|Abbott Enzymatic reagent on the Abbott Architect ci8200  analyser 
|Abbott Enzymatic reagent on the Abbott Architect ci8200  analyser 
|-
|-

Revision as of 13:53, 31 January 2025

Overview

Department Biochemistry
Test Code LIPS
Synonyms Lipid profile 
Turnaround Time 2 hours 
Stability – Add test 24 hours

Specimen Requirements

Specimen Type Plasma

Serum

Preferred 6 mL Red-Top
Acceptable 4 mL Li-Hep Green-Top  
Specimen Transportation
Pediatric Requirements 600 µL  Li-Hep Microtainer Paediatric tube

Aliquot Requirements

Sample Type
Minimum Volume
Aliquot Transportation

Clinical Information

Reference Intervals
Test Method Abbott Enzymatic reagent on the Abbott Architect ci8200 analyser 
Advanced Notice
Patient Preparation

Comments

Help for Lipid Studies Interpretation

Reported Comments:

1. All reports get this comment (see below for additional information on optimal

levels):

"Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred."

2. All reports get this comment, unless superseded by any

one or more of the other comments below:

"Cardiovascular risk should be addressed by lifestyle and

pharmacological interventions in subjects with 5-year CV risk

greater than 15%."

3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: